IFAM
ACAD icon

Institutional & Family Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Institutional & Family Asset Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-38
Closed -$2K – 826
2020
Q2 		$2K Sell
38
-11
-22% -$528 ﹤0.01% 669
2020
Q1 		$2K Buy
49
+12
+32% +$494 ﹤0.01% 619
2019
Q4 		$2K Hold
37
– – ﹤0.01% 699
2019
Q3 		$1K Sell
37
-1
-3% -$30 ﹤0.01% 759
2019
Q2 		$1K Buy
+38
New +$971 ﹤0.01% 775

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Institutional & Family Asset Management's ACAD Position: Q3 2020 in Review

Institutional & Family Asset Management sold out of Acadia Pharmaceuticals (ACAD) in Q3 2020, closing a stake of 38 shares — an estimated $2K sold.

Institutional & Family Asset Management first reported a position in ACAD in Q2 2019 and held it in 5 quarters. The position peaked at $2K in Q2 2020. 267 funds tracked by Wall St. Rank hold ACAD as of Q3 2020.

  • Institutional & Family Asset Management reported no remaining Acadia Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Institutional & Family Asset Management sold 38 Acadia Pharmaceuticals shares in Q3 2020, an estimated $2K.
  • Institutional & Family Asset Management first reported a position in Acadia Pharmaceuticals in Q2 2019 and held it in 5 quarters.
  • Institutional & Family Asset Management's Acadia Pharmaceuticals position peaked at $2K in Q2 2020.
  • 267 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2020.

Based on Institutional & Family Asset Management's 13F filing for Q3 2020, filed 30 Oct 2020.